The KEGG enrichment analysis revealed that the AL compounds targeted multiple signaling pathways related to depression, which primarily include neuroactive ligand–receptor interaction, the calcium signaling pathway, dopaminergic synapse, the IL-17 signaling pathway, and the pathways of neurodegeneration. Here, IL17A is linked to depressive disorder.